CATALAYER NEWS
FDA accepts Genentech filing for Tecentriq in colon cancer
Source: Investing.com · 2026-06-11
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Barclays cuts Vodafone to “equal weight”on sustained Germany weakness
2026-06-11
Forterra CFO Ben Guyatt to depart after 20 years
2026-06-11
Strix Group appoints Andy Rainforth as chief executive
2026-06-11
Fair Oaks Income sets sterling dividend rate at 8.62p per share
2026-06-11
Kontron shares rise 4.9% after Ennoconn takeover offer
2026-06-11
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets